AURA
Aura Biosciences Inc
6.50$
+4.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | -25.4% | +9.0% | +5.5% | +11.3% | +15.6% | +2.0% | +7.0% | +1.5% | -8.5% | +33.3% | -19.0% | -5.6% | +2.3% | +0.0% | -7.0% | +0.0% | +3.1% | +0.0% | -300.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -145.7% | – | – | |
| – | -16.1% | -46.4% | +24.3% | +18.1% | +58.5% | -4.0% | +25.4% | +3.7% | +14.9% | +18.7% | +16.5% | +9.5% | +5.0% | +2.0% | +31.4% | -15.9% | -1.0% | +0.9% | +31.1% | +4.5% | -2.0% | -3.1% | -1.3% | +27.7% | +10.0% | – | |
| – | -28.5% | -7.1% | +74.9% | +27.5% | +24.5% | +16.6% | +44.2% | +24.3% | -5.0% | +10.6% | -6.5% | +13.1% | +2.3% | -1.9% | -11.0% | +16.8% | +11.8% | +5.3% | -11.7% | +4.0% | +0.7% | -0.1% | -6.8% | +29.3% | +150.8% | – | |
| – | -18.1% | -41.0% | +35.2% | +20.7% | +48.5% | +1.1% | +30.7% | +10.2% | +7.8% | +16.2% | +9.7% | +10.4% | +4.3% | +1.0% | +21.0% | -11.2% | +3.4% | +2.1% | +19.7% | +4.4% | -2.5% | -1.4% | -2.4% | +28.0% | +37.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +0.0% | +300.0% | +25.0% | +160.0% | +92.3% | +1,068.0% | +65.4% | +65.6% | +188.2% | – | – | – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | – | – | -211.8% | – | – | -1,570.8% | – | – | -109.1% | – | – | – | -66.4% | -102.2% | – | -44.2% | -25.0% | +166.7% | -45.8% | -42.3% | -26.7% | +163.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.